RSV research Group - Group Bont-Meyaard
RSV research Group - Group Bont-Meyaard
Aboutuitklapper, klik om te openen
The RSV Research Group has the vision to combine clinical and basic research to decrease the global burden of RSV infection. Our mission is to improve knowledge of RSV epidemiology, and to develop safe and effective therapeutic and preventive interventions. The RSV Research Group consists of clinician scientists and lab researchers focusing on the epidemiology and pathogenesis of RSV bronchiolitis. RSV infections cause a major burden for patients, their parents and society. RSV infection is the second most frequent cause of death during infancy, only malaria is associated with higher mortality.
Group membersuitklapper, klik om te openen
Group Leaders
prof. dr. L.J. Bont Full Professor
Dr. Bont has regular interaction with pharmaceutical and other industrial partners. He has not received personal fees or other personal benefits. UMCU has received major funding (>€100,000 per industrial partner) for investigator initiated studies from AbbVie, MedImmune, Janssen, Pfizer, the Bill and Melinda Gates Foundation and MeMed Diagnostics. UMCU has received major cash or in kind funding as part of the public private partnership IMI-funded RESCEU project from GSK, Novavax, Janssen, AstraZeneca, Pfizer and Sanofi. UMCU has received major funding by Julius Clinical for participating in the INFORM study sponsored by MedImmune. UMCU has received minor funding for participation in trials by Regeneron and Janssen from 2015-2017 (total annual estimate less than €20,000). UMCU received minor funding for consultation and invited lectures by AbbVie, MedImmune, Ablynx, GSK, Bavaria Nordic, MabXience, Novavax, Pfizer, Janssen (total annual estimate less than €20,000). Dr. Bont is the founding chairman of the ReSViNET Foundation.
prof. dr. L. Meyaard Full Professor
Senior researchers
- Joanne Wildenbeest
- Katrien Oude Rengerink
Technician
- Margreet Westerlaken
PhD students
- Koos Korsten
- Natalie Mazur
- Sjanna Besteman
- Arthur van Stigt
- Annefleur Langedijk
- Yvette Lowensteyn
- Roy Zuurbier
- Marie Billard
Patient advisory board
- Nicole Derksen-Lazet, lead Patient Advisory Board
- Inge Oliemans, communication Patient Advisory Board
Research nurses
- Loes Nibbelke
- Brigitte Buiteman
ReSViNET Foundation
Leyla Kragten-Tabatabaie, Board of Directors ReSViNET Foundation
Key publicationsuitklapper, klik om te openen
- Blanken, M. O., et al. (2013). "Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants." 368(19): 1791-1799.Blanken, M. O., et al. (2013). View
- Mazur, N. I., et al. (2015). "Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics." Lancet Respir Med 3(11): 888-900. View
- van Houten, C. B., et al. (2017). "A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study." Lancet Infect Dis 17(4): 431-440. View
- Scheltema, N. M., et al. (2018). "Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial." Lancet Respir Med 6(4): 257-264. View
- Mazur, N. I., et al. (2018). "The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates." Lancet Infect Dis 18(10): e295-e311. View
RSV infection and wheeze in moderate-to-late preterm infants prediction and cost-effectiveness
Marteen Blanken
2019
Improving diagnosis of bacterial infections
Chantal van Houten
2019
Respiratory syncytial virus-related disease burden in young children
Nienke Scheltema
2018
Innate immunity in RSV infection
Tina Faber
2017
Grantsuitklapper, klik om te openen
| 2017 - Respiratory Syncitial virus Consortium in Europe(RESCUE, IMI) | |
|---|---|
| 2016 - RSV GOLD (BMGF) | |
| 2014 - Longfonds Consortium Grant |
Support our researchuitklapper, klik om te openen
- Resvinet foundation
Collaborationsuitklapper, klik om te openen
RSV GOLD
funded by Bill and Melinda Gates Foundation
IMPRIND
for biomarker research to diagnose bacterial infection
ReSViNET Network
for RSV Research, chairman
TAILORED Network
for biomarker discovery of virus versus bacterial respiratory tract infection
RESCEU Network
for RSV Burden of Disease studies (funded by IMI/H2020)
RSV Society
under ISIRV
Education & Coursesuitklapper, klik om te openen
- International conference: RSVVW, Accra, Ghana
- Summer school on Global Child Health, Utrecht
Research programsuitklapper, klik om te openen
- Infection and Immunity
- Child Health
Research interests/topicsuitklapper, klik om te openen
Epidemiology and pathogenesis of RSV bronchiolitis